FDA 483 - Vista Lifesciences, Inc. - February 11, 2019

An FDA inspection of Vista Lifesciences, Inc., a manufacturer in Englewood, CO, revealed significant deficiencies in their quality management system. The firm failed to adequately establish corrective and preventive action procedures and did not perform required quality audits. These issues indicate a lack of effective oversight and control over product quality and compliance.